1. home
  2. > business
  3. > Sun Pharma cracks on insider trading allegations, SEBI to reopen case
replay trump newslist
up NEXT IN 5 SECONDS sports newslist
tap to unmute
00:00/00:00
NaN/0

Sun Pharma cracks on insider trading allegations, SEBI to reopen case

Dec 03, 2018 11:54 IST

Pharma major Sun Pharmaceutical Industries plunged in trade today on reports SEBI is likely to reopen an investigation into insider trading allegations against the company and its promoters, that was previously settled through the consent mechanism. Sun Pharma has said the information is available in public domain and is 10-15 years old. The company will conduct an investor call later today to update investors. Sun Pharma, its Managing Director Dilip Shanghvi, and nine others had settled the insider trading probe, paying Rs 18 lakh against the settlement charges in 2017.

Business